登录 | 注册    关注公众号  
微信公众号
搜索
 >  Protein>CD133 >CD3-H52H1

Human CD133 Full Length Protein, His Tag (Nanodisc)

分子别名(Synonym)

CD133,PROM1,PROML1,Prominin-1,AC133

表达区间及表达系统(Source)

Human CD133 Full Length Protein, His Tag (CD3-H52H1) is expressed from human 293 cells (HEK293). It contains AA Gly 20 - His 865 (Accession # O43490-1).

Predicted N-terminus: Gly 20

Request for sequence

蛋白结构(Molecular Characterization)

CD133 Structure

The CD133 carries a polyhistidine tag at the C-terminus with calculated MW of 97.2 kDa and migrates as 100-115 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation. The membrane scaffold protein (MSP1D1) has calculated MW of 24.7 kDa, and it migrates as 25 kDa under reducing (R) condition (SDS-PAGE).

Nanodiscs are a new class of model membranes that are being used to solubilize and study a range of integral membrane proteins and membrane-associated proteins. The Nanodisc bilayer is bounded by a membrane scaffold protein (MSP1D1) coat that confers enhanced stability and a narrow particle size distribution.

The nanodisc assembles from a mixture of full length membrane protein in detergent, phospholipid micelles and membrane scaffold protein(MSP1D1) upon removal of the detergent.

内毒素(Endotoxin)

Less than 1.0 EU per μg by the LAL method.

纯度(Purity)

>90% as determined by SDS-PAGE.

制剂(Formulation)

Supplied as 0.2 μm filtered solution in 50 mM HEPES, 150 mM NaCl, pH7.5 with trehalose as protectant.

Contact us for customized product form or formulation.

运输(Shipping)

This product is supplied and shipped with dry ice, please inquire the shipping cost.

存储(Storage)

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

  1. The product MUST be stored at -70°C or lower upon receipt;
  2. -70°C for 3 months under sterile conditions.

质量管理控制体系(QMS)

  1. 质量管理体系(ISO, GMP)
  2. 质量优势
  3. 质控流程
*The isotype control of empty/mock nanodisc (Cat. No. APO-H51H3) is sold separately and not included in protein, you can follow this link for product information.
 

电泳(SDS-PAGE)

CD133 SDS-PAGE

Human CD133 Full Length Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.

 

活性(Bioactivity)-ELISA

CD133 ELISA

Immobilized Human CD133 Full Length Protein, His Tag (Cat. No. CD3-H52H1) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Human CD133 Antibody, Human IgG1 with a linear range of 0.2-4 ng/mL (QC tested).

Protocol

 

活性(Bioactivity)-FACS

CD133 FACS

2e5 of Anti-CD133 CAR-293 cells were stained with 100 μL of 3 μg/mL of Human CD133 Full Length Protein, His Tag (Cat. No. CD3-H52H1) and negative control protein respectively, washed and then followed by PE-anti-His Tag antibody and analyzed with FACS (QC tested).

Protocol

 
评论(2)
  1. 138XXXXXXX4
  2. 3人赞
  3. 购买该产品主要用于细胞培养实验中细胞因子添加物 产品性能较好 解决了我们之前细胞状态一直不好的困惑 而且包装较好 物流迅速 好评
  4. 2023-3-29
  1. 151XXXXXXX5
  2. 2人赞
  3. 换了很多家的同类型的抗体,没想到就这样的最靠谱,无论是发货速度、售后服务,还是对产品的定价都无可挑剔,这简直就是广大科研工作者的梦中情人,这么优秀的品牌和试剂值得评价一番,希望品牌越来越好
  4. 2023-3-29
  1. 131XXXXXXX6
  2. 1人赞
  3. 买来用于细胞试验,试验结果符合预期,非常可靠。产品一如既往的好用,服务很好,反馈响应及时,针对问题还会帮忙提供解决方案!
  4. 2023-3-29
 
ACRO质量管理体系
 
 

背景(Background)

Prominin-1 is also known as CD133, Antigen AC133, PROM1, PROML1 and MSTP061. Is used as marker for hematopoietic stem and progenitor cells (HSPC) for somatic stem cell isolation. May play a role in cell differentiation, proliferation and apoptosis . Binds cholesterol in cholesterol-containing plasma membrane microdomains and may play a role in the organization of the apical plasma membrane in epithelial cells. During early retinal development acts as a key regulator of disk morphogenesis. Involved in regulation of MAPK and Akt signaling pathways. In neuroblastoma cells suppresses cell differentiation such as neurite outgrowth in a RET-dependent manner.

 

前沿进展

Loading ...
 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
CD133靶点信息
英文全称:CD133
中文全称:CD133抗原
种类:Homo sapiens
上市药物数量:0详情
临床药物数量:1详情
最高研发阶段:临床二期
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定